ACI Welcomes CJEU CBD Ruling
The ACI welcomes today’s ruling from the Court of Justice of the European Union (CJEU) which marks a landmark day for the CBD industry.
ACI Meets Demand For Novel Foods Advice By Strengthening Regulatory Consultancy Team
The ACI is pleased to announce an additional new hire to enable us to meet the demand from CBD companies seeking guidance from our Regulatory Consultancy Team to finalise their novel foods applications.
It’s ACI’s Birthday – Here’s A Look At What We’ve Achieved In Our First Year
A year ago, the Association for the Cannabinoid Industry (ACI) was launched by a group of cannabinoid enthusiasts and experts. Here’s a few highlights, of the many significant achievements, we have made within the cannabinoid space in our first year.
ACI Statement on ACNFP’s CBD Clarifications
The ACI welcomes the recent clarifications from The Advisory Council for Novel Foods and Processes (ACNFP) relating to the data requirements for CBD novel foods applications. The ACNFP, who are an advisory committee to the FSA, highlighted the following key points, which emphasise the importance of ACI’s consortium approach to generating this data.
ACI Announce Landmark Safety Study Consortium as Regulator Clarifies Toxicology Requirements for Novel Foods
Today the Association for the Cannabinoid Industry (ACI), in partnership with Advanced Development and Safety Laboratory (ADSL), is announcing the launch of a landmark study with a consortium of CBD companies who are together committed to building a sustainable, safe and fully compliant industry in the UK.
ACI Welcomes FSA’s Guidance on CBD Novel Foods Application Requirements
The ACI today welcomes the guidance issued by the Food Standards Agency today which fully validates our consortium approach to generating toxicology safety study data for novel foods applications for CBD in line with the requirements of the Government Committee on Toxicity.
Critical novel foods update: FSA Confirms that Valid CBD Novel Foods Applications Must Include Toxicology Safety Study Data
With just 6 months remaining, for CBD companies to have a valid novel foods application for each of their products, the ACI has received confirmation from the FSA that these dossiers must include toxicology safety study data and literature-based information is not sufficient.
ACI Announces “The Future of CBD in Grocery” Webinar in Partnership with The Grocer
The ACI will host their latest in a series of webinars on 22 September, in conjunction with the UK’s leading magazine for the FMCG industry, The Grocer and one of North America’s most established cannabis companies, Columbia Care.
The ACI to Partner with VOXPO for B2C and B2B CBD Event
The ACI will host a series of panels at the upcoming VOXPO virtual event which runs from July 31 to August 2. The ACI are educational partners for the event and our panels will discuss issues relevant to CBD companies and consumers.
The ACI Responds to Global Regulatory Calls for Evidence of CBD Safety by Launching Study Consortium
The ACI today announces it will spearhead a CBD Safety Study Consortium to generate data to assess the safety of CBD. This move is in response to calls from regulators around the world who are highlighting the lack of evidence relating to the safety of CBD.
